500 Participants Needed

Precision Medicine for Cancer

(MOHCCN-O Trial)

Recruiting at 2 trial locations
SC
PC
Overseen ByPM2C Central Office
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University Health Network, Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on improving cancer treatments by examining how individual differences in DNA, environment, and lifestyle affect treatment outcomes. The researchers aim to advance precision medicine, tailoring treatments to each patient's unique cancer profile. Individuals with confirmed blood or solid tumor cancers who can provide necessary health data and samples may be suitable candidates. Participants will contribute valuable information that could lead to breakthroughs in cancer care. As a Phase 3 trial, this treatment is in the final step before FDA approval, offering participants the opportunity to contribute to a potentially groundbreaking cancer therapy.

Why are researchers excited about this trial?

Researchers are excited about the Marathon of Hope Cancer Centres Network because it aims to revolutionize cancer treatment by using precision medicine techniques. Unlike standard cancer treatments that often take a one-size-fits-all approach, this initiative uses advanced genomic profiling to tailor therapies specifically to the genetic makeup of an individual's cancer. This personalized approach has the potential to increase treatment effectiveness and reduce side effects, offering hope for better outcomes. Researchers are eager to uncover how this method can transform cancer care and improve patient survival rates.

Who Is on the Research Team?

LS

Lillian Siu, MD

Principal Investigator

University Health Network, Toronto

Are You a Good Fit for This Trial?

Inclusion Criteria

My cancer has been confirmed by lab tests.
My condition meets the top criteria for diagnosis.
I have enough tissue and blood samples for detailed testing.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection and Analysis

Consolidate and annotate clinical and genomic data from participants

5 years

Follow-up

Participants are monitored for safety and effectiveness after data collection

5 years

What Are the Treatments Tested in This Trial?

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Health Network, Toronto

Lead Sponsor

Trials
1,555
Recruited
526,000+

Queen's University, Kingston, Ontario

Collaborator

Trials
9
Recruited
83,900+

Ottawa Hospital Research Institute

Collaborator

Trials
585
Recruited
3,283,000+

Queen's University

Collaborator

Trials
382
Recruited
122,000+

Queen's University

Collaborator

Kingston Health Sciences Centre

Collaborator

Trials
312
Recruited
112,000+

Princess Margaret Hospital, Canada

Collaborator

Trials
121
Recruited
40,000+

Ontario Institute for Cancer Research

Collaborator

Trials
24
Recruited
9,200+

Terry Fox Research Institute

Collaborator

Trials
11
Recruited
1,600+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity